Brewin Dolphin Wealth Management LTD Magenta Therapeutics, Inc. Transaction History
Brewin Dolphin Wealth Management LTD
- $917 Million
- Q2 2022
A detailed history of Brewin Dolphin Wealth Management LTD transactions in Magenta Therapeutics, Inc. stock. As of the latest transaction made, Brewin Dolphin Wealth Management LTD holds 1,300 shares of MGTA stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,300
Previous 1,300
-0.0%
Holding current value
$0
Previous $4,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding MGTA
# of Institutions
2Shares Held
442KCall Options Held
0Put Options Held
0About Magenta Therapeutics, Inc.
- Ticker MGTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,890,500
- Description
- Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...